Showing results (891-900 of 1,334) with videos related to
Sort By:
Pageof 134
Plos Biology|September 28, 2023
A few essential genetic loci distinguish Penstemon species with flowers adapted to pollination by bees or hummingbirdsCarolyn A Wessinger, Amanda M Katzer, Paul M Hime, et al.The Journal of Infectious Diseases|December 4, 2012
Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202Grace A McComsey, Eric S Daar, MaryAnn O'Riordan, et al.HIV Clinical Trials|May 14, 2008
Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIVAnn C Collier, Camlin Tierney, Gerald F Downey, et al.Human Mutation|November 30, 2019
SCN1A variants from bench to bedside-improved clinical prediction from functional characterizationAndreas Brunklaus, Stephanie Schorge, Alexander D Smith, et al.AIDS Research and Therapy|January 5, 2023
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistanceRobert A Salata, Beatriz Grinsztejn, Justin Ritz, et al.The Journal of Infectious Diseases|April 25, 2001
Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDSM M Berrey, T Schacker, A C Collier, et al.Annals of Internal Medicine|July 4, 2001
Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV diseaseE L Murphy, A C Collier, L A Kalish, et al.Optics Express|October 6, 2012
High-energy, ceramic-disk Yb:LuAG laser amplifierM Siebold, M Loeser, F Roeser, et al.The Journal of Infectious Diseases|June 23, 2016
Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected IndividualsPhilip M Grant, Douglas Kitch, Grace A McComsey, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 1, 2014
Regulatory T cells and the risk of CMV end-organ disease in patients with AIDSAdriana Weinberg, Ronald Bosch, Kara Bennett, et al.Pageof 134